Epigenomes as therapeutic targets

Pharmacology & Therapeutics
Christopher A Hamm, Fabricio F Costa

Abstract

Epigenetics is a molecular phenomenon that pertains to heritable changes in gene expression that do not involve changes in the DNA sequence. Epigenetic modifications in a whole genome, known as the epigenome, play an essential role in the regulation of gene expression in both normal development and disease. Traditional epigenetic changes include DNA methylation and histone modifications. Recent evidence reveals that other players, such as non-coding RNAs, may have an epigenetic regulatory role. Aberrant epigenetic signaling is becoming to be known as a central component of human disease, and the reversible nature of the epigenetic modifications provides an exciting opportunity for the development of clinically relevant therapeutics. Current epigenetic therapies provide a clinical benefit through disrupting DNA methyltransferases or histone deacetylases. However, the emergence of next-generation epigenetic therapies provides an opportunity to more effectively disrupt epigenetic disease states. Novel epigenetic therapies may improve drug targeting and drug delivery, optimize dosing schedules, and improve the efficacy of preexisting treatment modalities (chemotherapy, radiation, and immunotherapy). This review discusses the epigen...Continue Reading

References

Oct 1, 1984·Molecular and Cellular Biology·E FlatauP A Jones
Apr 16, 1998·Genes & Development·K Struhl
Oct 16, 1999·Science·A P Wolffe, M A Matzke
May 11, 2000·Proceedings of the National Academy of Sciences of the United States of America·B H RamsahoyeR Jaenisch
Aug 11, 2001·Science·W ReikJ Walter
Jan 10, 2002·Genes & Development·Adrian Bird
Jan 11, 2002·Developmental Biology·Fátima SantosWendy Dean
Jun 4, 2002·Nature Reviews. Genetics·Peter A Jones, Stephen B Baylin
Apr 19, 2003·Science·Amir EdenRudolf Jaenisch
Apr 19, 2003·Science·François GaudetRudolf Jaenisch
Jan 21, 2004·Nature Reviews. Cancer·Andrew P Feinberg, Benjamin Tycko
Mar 29, 2005·The Oncologist·Edvardas KaminskasRichard Pazdur
Nov 18, 2005·Gene·Michele A GlozakEdward Seto
Feb 18, 2006·Nature Reviews. Drug Discovery·Christine B Yoo, Peter A Jones
Dec 2, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Jan H BeumerMerrill J Egorin
Dec 2, 2006·Stem Cells·Fabrício F CostaBertha Brodin
May 25, 2007·Nature·Andrew P Feinberg
Jun 15, 2007·Advances in Immunology·Il-mi OkazakiTasuku Honjo
Jul 10, 2007·Cancer Research·Christine B YooPeter A Jones
Aug 22, 2007·Journal of Cellular Physiology·Tina Branscombe Miranda, Peter A Jones
Sep 6, 2007·Epigenetics : Official Journal of the DNA Methylation Society·Adam R Karpf
Oct 24, 2007·Molecular Cancer Research : MCR·Milos DokmanovicPaul A Marks
Jan 30, 2008·Gene·Fabrício F Costa
Apr 22, 2008·International Journal of Cancer. Journal International Du Cancer·Carlo Stresemann, Frank Lyko
Mar 28, 2009·Cellular and Molecular Life Sciences : CMLS·Igor P Pogribny, Frederick A Beland
Jun 11, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Jean-Pierre J Issa, Hagop M Kantarjian
Sep 5, 2009·Chromosoma·Matthias Schaefer, Frank Lyko
Feb 6, 2010·Genome Research·Louise LaurentChia-Lin Wei
May 6, 2010·Genome Biology·Mihaela Pertea, Steven L Salzberg

❮ Previous
Next ❯

Citations

Feb 11, 2016·Biomarkers in Medicine·Anna Rita BianchiMaria Rosaria Faraone Mennella
Feb 21, 2016·Pharmacology & Therapeutics·Susumu OhyaKatsuhiko Muraki
Mar 26, 2016·Pharmacology & Therapeutics·Yingmei Zhang, Jun Ren
Dec 10, 2015·Oxidative Medicine and Cellular Longevity·Anna Maria Mileo, Stefania Miccadei
Aug 4, 2015·Epigenetics & Chromatin·Diana L BernsteinKlaus H Kaestner
Jun 2, 2016·Oxidative Medicine and Cellular Longevity·Pierpaola DavalliDomenico D'Arca
Jun 10, 2016·Critical Reviews in Toxicology·Emma L MarczyloTimothy W Gant
Jun 12, 2016·Journal of Controlled Release : Official Journal of the Controlled Release Society·Rui Xue ZhangXiao Yu Wu
Jun 29, 2016·ACS Chemical Biology·Tyler D HuberJon S Thorson
Sep 2, 2016·Journal of Translational Medicine·Raffaele FrazziAlfredo Cesario
Nov 4, 2016·Epigenomics·Pei LiuZhenfeng Duan
Apr 28, 2016·Journal of Neurochemistry·Ullrich WüllnerIna Schmitt
Oct 18, 2016·Journal of Cellular Biochemistry·Fernanda WisnieskiMarília Cardoso Smith
Jan 13, 2017·Journal of Proteome Research·Gisele F A PicchiLyris M F de Godoy
Jun 20, 2018·Journal of Veterinary Pharmacology and Therapeutics·Marilyn N MartinezKatrina L Mealey
Dec 24, 2017·Biochemical Society Transactions·Gisela I MazairaMario D Galigniana
May 18, 2019·Clinical Epigenetics·Shizhao LiTrygve O Tollefsbol
Jul 25, 2019·Lab on a Chip·Chengyu DengChang Lu
Mar 17, 2017·Clinical Chemistry and Laboratory Medicine : CCLM·José Luis García-GiménezFabian Sanchis-Gomar
Jul 1, 2018·Genes·Francesco MorenaSabata Martino
Mar 25, 2017·Nutrition Reviews·Delphine LeyFrédéric Gottrand
Mar 1, 2019·Proceedings of the National Academy of Sciences of the United States of America·Shuvojit BanerjeeRobert H Silverman
Jan 1, 2017·Cellular and Molecular Life Sciences : CMLS·Nhat-Tu LeJun-Ichi Abe
Oct 1, 2015·Hepatic Oncology·Jeroen DekervelChris Verslype
Feb 19, 2016·Physiological Reviews·Jude S MortonSandra T Davidge
Nov 19, 2020·Alcoholism, Clinical and Experimental Research·Safdar JawaidStephanie M Ford
Jan 6, 2021·Antioxidants·Melania Guerrero-HueJuan Antonio Moreno
Dec 16, 2019·The International Journal of Biochemistry & Cell Biology·Hossein HosseiniReza Meshkani
May 6, 2021·Physiological Reviews·Jun RenYingmei Zhang

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Epigenetics

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cancer Metabolism

In order for cancer cells to maintain rapid, uncontrolled cell proliferation, they must acquire a source of energy. Cancer cells acquire metabolic energy from their surrounding environment and utilize the host cell nutrients to do so. Here is the latest research on cancer metabolism.

Cancer Epigenetics and Senescence (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may be involved in regulating senescence in cancer cells. This feed captures the latest research on cancer epigenetics and senescence.

Cellular Immunometabolism

Immunometabolism involves not only the way metabolites are digested by the immune system, but the way in which they can alter the pathway of the immune system. These responses occur in day-to-day healthy cell functioning, but can result in diseases, such as autoimmune disorders. Discover the latest research on cellular immunometabolism here.

Cell Signaling & Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. This feed covers the latest research on signaling and epigenetics in cell growth and cancer.

Cell Checkpoints & Regulators

Cell cycle checkpoints are a series of complex checkpoint mechanisms that detect DNA abnormalities and ensure that DNA replication and repair are complete before cell division. They are primarily regulated by cyclins, cyclin-dependent kinases, and the anaphase-promoting complex/cyclosome. Here is the latest research.

Cancer Epigenetics & Methyl-CpG (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. Here is the latest research on cancer epigenetics and methyl-CpG binding proteins including ZBTB38.

Cancer Epigenetics and Chromatin (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on chromatin and its role in cancer epigenetics please follow this feed to learn more.

Cancer Epigenetics and Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.

Cancer Epigenetics Chromatin Complexes (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on chromatin complexes and their role in cancer epigenetics.

Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.

Cancer Vaccines

Cancer vaccines are vaccines that either treat existing cancer or prevent development of a cancer.

Related Papers

Journal of the National Cancer Institute
Levy KopelovichJudith R Fay
Current Opinion in Pediatrics
Andrea Baccarelli, Valentina Bollati
Current Opinion in Investigational Drugs
Muller Fabbri
© 2021 Meta ULC. All rights reserved